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5-hydroxytryptamine (50HT) may have an important role in 
the mediation of coronary artery vasospasm. There has been 
no attempt to characterise the nature of the receptors 
that mediate the actions of 5-HT on human coronary art- 
eries, or to examine the effect of tissue pathology on the 
receptor subtypes. Experiments were performed using 138 
segments of epicardial coronary artery used l-8h after 
removal from 21 patients (2-66 years) undergoing heart 
transplantion. Ring segments were suspended in a 51~1 organ 
bath containing a modified Tyrodes solution, at 37“C and 
gassed with 95%/5X 02/CO2. 5-HT and (*)-alpha-methyl-5-HT 
(a-me-5-HT) a selective 5-HT2 receptor agonist, ‘contracted 
vessel segments from normal arteries as well as those 
affected by atherosclerosis. CR43175 a selective 5-HTl- 
like receptor agonist contracted healthy arterieu to 30X, 
and diseased arteries to 60% of the effect of a-me-5-HT. 
The maximum effect of the a-me-5-HT was significantly 
reduced (~(0.05) In diseased arteries, as was the effect 
of 9&&l potassium indicating a decreased contractability 
of the smooth muscle. However, the response to the 5_HTl- 
like receptor agonist 6143175, was unchanged in the normal 
diseased arteries. Furthermore, this preservation of 
response in diseased arteries was found to occur preferent- 
ially in segments just distal to areas of atheromatous 
lesions. No relaxations were observed for any of the 5-HT 
agonists in pre-constricted artery segments. It is conclud- 
ed that 5-HT acts on both 5-HTllike and 5-HT2 receptors, 
and that the 5-HTI-like receptors are relatively up- 
regulated in arteries affected with atherosclerosis, and 
that this Is found in areas where vasospasm usually occurs. 
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